Spire Wealth Management - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$162,000
+2.5%
148,8000.0%0.01%
+75.0%
Q1 2022$158,000
+39.8%
148,800
+18.3%
0.00%
+33.3%
Q4 2021$113,000
+370.8%
125,800
+598.9%
0.00%
+200.0%
Q3 2021$24,000
-11.1%
18,000
+28.6%
0.00%0.0%
Q2 2021$27,000
+200.0%
14,000
+600.0%
0.00%
Q1 2021$9,0002,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Burrage Capital Management LLC 2,470,332$8,967,0006.83%
Psagot Value Holdings Ltd. 470,255$1,707,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 212,591$772,0000.02%
UBS OCONNOR LLC 150,000$544,000,0000.01%
GSA CAPITAL PARTNERS LLP 10,042$36,0000.01%
Renaissance Technologies 488,634$1,774,0000.00%
Squarepoint Ops LLC 22,068$80,0000.00%
BANK OF AMERICA CORP /DE/ 222$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 50,280$183,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders